ArticleJCI insight2021
11-Ketotestosterone is the predominant active androgen in prostate cancer patients after castration.
Gido Snaterse et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this paperpooled itcites it